{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:55:08Z","timestamp":1793663708725,"version":"4.5.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["arthroplastyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Arthroplasty"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.arth.2021.10.001","type":"journal-article","created":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T03:30:10Z","timestamp":1634095810000},"page":"379-384.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Aspirin Thromboprophylaxis Is Associated With Less Major Bleeding Events Following Total Joint Arthroplasty"],"prefix":"10.1016","volume":"37","author":[{"given":"Noam","family":"Shohat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanne","family":"Ludwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7337-3321","authenticated-orcid":false,"given":"Graham S.","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney","family":"Streicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0933-6806","authenticated-orcid":false,"given":"Emanuele","family":"Chisari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6985-5870","authenticated-orcid":false,"given":"Javad","family":"Parvizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arth.2021.10.001_bib1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.arth.2019.08.049","article-title":"Have venous thromboembolism rates decreased in total hip and knee arthroplasty?","volume":"35","author":"Warren","year":"2020","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.10.001_bib2","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.arth.2016.10.020","article-title":"The incidence and Economic Burden of in-hospital venous thromboembolism in the United States","volume":"32","author":"Shahi","year":"2017","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.10.001_bib3","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.arth.2018.12.015","article-title":"Utilization Patterns, efficacy, and complications of venous thromboembolism prophylaxis strategies in primary hip and knee arthroplasty as reported by American board of orthopedic surgery Part II Candidates","volume":"34","author":"Runner","year":"2019","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.10.001_bib4","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2106\/JBJS.19.01135","article-title":"Selection bias, orthopaedic Style: Knowing what We Don\u2019t Know about aspirin","volume":"102","author":"Pellegrini","year":"2020","journal-title":"J\u00a0Bone Joint Surg"},{"key":"10.1016\/j.arth.2021.10.001_bib5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2106\/JBJS.16.00147","article-title":"Low-dose aspirin is effective chemoprophylaxis Against clinically important venous thromboembolism following total joint arthroplasty: a preliminary analysis","volume":"99","author":"Parvizi","year":"2017","journal-title":"J\u00a0Bone Joint Surg"},{"key":"10.1016\/j.arth.2021.10.001_bib6","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1302\/0301-620X.99B11.BJJ-2017-0337.R2","article-title":"Aspirin and the prevention of venous thromboembolism following total joint arthroplasty: commonly asked questions","volume":"99-B","author":"Azboy","year":"2017","journal-title":"Bone Joint J"},{"key":"10.1016\/j.arth.2021.10.001_bib7","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1016\/j.arth.2016.04.004","article-title":"Aspirin as thromboprophylaxis in hip and knee arthroplasty: a Systematic review and Meta-analysis","volume":"31","author":"An","year":"2016","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.10.001_bib8","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/j.arth.2018.03.001","article-title":"Low-dose aspirin is safe and effective for venous thromboembolism prophylaxis following total knee arthroplasty","volume":"33","author":"Faour","year":"2018","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.10.001_bib9","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.arth.2019.02.006","article-title":"Current Practice Trends in primary hip and knee Arthroplasties among members of the American association of hip and knee surgeons: a Long-term Update","volume":"34","author":"Abdel","year":"2019","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.10.001_bib10","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.artd.2020.01.010","article-title":"Aspirin used for venous thromboembolism prophylaxis in total hip arthroplasty decreases heterotopic ossification","volume":"6","author":"Vaz","year":"2020","journal-title":"Arthroplasty Today"},{"key":"10.1016\/j.arth.2021.10.001_bib11","first-page":"7","article-title":"Type of anticoagulant used after total knee arthroplasty affects the rate of knee manipulation for postoperative","volume":"100","author":"Kahlenberg","year":"2018","journal-title":"Stiffness"},{"key":"10.1016\/j.arth.2021.10.001_bib12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.arth.2015.07.001","article-title":"Administration of aspirin as a prophylaxis Agent against venous thromboembolism results in lower incidence of Periprosthetic joint infection","volume":"30","author":"Huang","year":"2015","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.10.001_bib13","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2106\/JBJS.18.00143","article-title":"The Use of aspirin for prophylaxis Against venous thromboembolism decreases mortality following primary total joint arthroplasty","volume":"101","author":"Rondon","year":"2019","journal-title":"J\u00a0Bone Joint Surg"},{"key":"10.1016\/j.arth.2021.10.001_bib14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.arth.2015.04.048","article-title":"Direct costs of aspirin versus warfarin for venous thromboembolism prophylaxis after total knee or hip arthroplasty","volume":"30","author":"Gutowski","year":"2015","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.10.001_bib15","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1161\/CIRCULATIONAHA.119.043318","article-title":"Anticoagulation-Related major bleeding in patients with Atrial Fibrillation","volume":"140","author":"Nelson","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.arth.2021.10.001_bib16","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s11239-013-0899-7","article-title":"Assessing bleeding risk in patients taking anticoagulants","volume":"35","author":"Shoeb","year":"2013","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.arth.2021.10.001_bib17","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.seminhematol.2014.02.002","article-title":"Direct oral anticoagulants and bleeding risk (in comparison to vitamin K antagonists and heparins), and the treatment of bleeding","volume":"51","author":"Palareti","year":"2014","journal-title":"Semin Hematol"},{"key":"10.1016\/j.arth.2021.10.001_bib18","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11999.0000000000000041","article-title":"Mobile Compression reduces bleeding-related readmissions and Wound complications after THA and TKA","volume":"476","author":"Arsoy","year":"2018","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.arth.2021.10.001_bib19","doi-asserted-by":"crossref","first-page":"800","DOI":"10.7326\/0003-4819-158-11-201306040-00004","article-title":"Aspirin versus low-molecular-weight heparin for Extended venous thromboembolism prophylaxis After total hip arthroplasty: a randomized trial","volume":"158","author":"Anderson","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.arth.2021.10.001_bib20","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1712746","article-title":"Aspirin or rivaroxaban for VTE prophylaxis after hip or knee arthroplasty","volume":"378","author":"Anderson","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.arth.2021.10.001_bib21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jamasurg.2018.3858","article-title":"Association of aspirin with prevention of venous thromboembolism in patients after total knee arthroplasty compared with other anticoagulants: a Noninferiority analysis","volume":"154","author":"Hood","year":"2019","journal-title":"JAMA Surg"},{"key":"10.1016\/j.arth.2021.10.001_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.arth.2021.01.025","article-title":"Non-inferiority of aspirin for venous thromboembolism prophylaxis After hip arthroplasty in a Statewide registry","author":"Muscatelli","year":"2021","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.10.001_bib23","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1007\/s11999-017-5394-6","article-title":"Venous thromboembolism prophylaxis After TKA: aspirin, warfarin, enoxaparin, or factor Xa Inhibitors?","volume":"475","author":"Bala","year":"2017","journal-title":"Clin Orthopaedics Relat Res"},{"key":"10.1016\/j.arth.2021.10.001_bib24","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1177\/1076029618772337","article-title":"Comparison of postoperative bleeding in total hip and knee arthroplasty patients receiving rivaroxaban, enoxaparin, or aspirin for thromboprophylaxis","volume":"24","author":"Lindquist","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.arth.2021.10.001_bib25","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.arth.2015.06.045","article-title":"Thromboembolism prophylaxis in hip arthroplasty: routine and high risk patients","volume":"30","author":"Nam","year":"2015","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.10.001_bib26","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1016\/j.arth.2017.05.042","article-title":"Comparative effectiveness and safety of drug prophylaxis for prevention of venous thromboembolism after total knee arthroplasty","volume":"32","author":"Cafri","year":"2017","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.10.001_bib27","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1538-7836.2009.03678.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients","volume":"8","author":"Schulman","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.arth.2021.10.001_bib28","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"Elm","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.arth.2021.10.001_bib29","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.arth.2016.02.077","article-title":"Individualized risk model for venous thromboembolism after total joint arthroplasty","volume":"31","author":"Parvizi","year":"2016","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.10.001_bib30","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1538-7836.2009.03678.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients","volume":"8","author":"Schulman","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.arth.2021.10.001_bib31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.arth.2016.02.074","article-title":"Aspirin is as effective as and safer than warfarin for patients at higher risk of venous thromboembolism undergoing total joint arthroplasty","volume":"31","author":"Huang","year":"2016","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.10.001_bib32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.thromres.2017.04.023","article-title":"Trends of thromboprophylaxis and complications after major lower limb orthopaedic surgeries in Korea: National Health Insurance Claim Data","volume":"155","author":"Kim","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.arth.2021.10.001_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.arth.2021.01.069","article-title":"Aspirin is safe for venous thromboembolism prophylaxis for patients with a history of Gastrointestinal issues","author":"Grosso","year":"2021","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2021.10.001_bib34","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.2106\/JBJS.L.00400","article-title":"Cost-effectiveness of low-molecular-weight heparin compared with aspirin for prophylaxis Against venous thromboembolism after total joint arthroplasty","volume":"95","author":"Schousboe","year":"2013","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2021.10.001_bib35","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.arth.2014.08.018","article-title":"Cost-effective prophylaxis Against venous thromboembolism after total joint arthroplasty: warfarin versus aspirin","volume":"30","author":"Mostafavi Tabatabaee","year":"2015","journal-title":"J\u00a0Arthroplasty"}],"container-title":["The Journal of Arthroplasty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540321007683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540321007683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:37:24Z","timestamp":1760121444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883540321007683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0883540321007683"],"URL":"https:\/\/doi.org\/10.1016\/j.arth.2021.10.001","relation":{},"ISSN":["0883-5403"],"issn-type":[{"value":"0883-5403","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirin Thromboprophylaxis Is Associated With Less Major Bleeding Events Following Total Joint Arthroplasty","name":"articletitle","label":"Article Title"},{"value":"The Journal of Arthroplasty","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arth.2021.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}